Jalota Deepika 4
4 · PMV Pharmaceuticals, Inc. · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Jalota Deepika
Chief Development Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-03-03+300,000→ 300,000 totalExercise: $1.32Exp: 2035-03-03→ Common Stock (300,000 underlying)
Holdings
- 123,024
Common Stock
Footnotes (2)
- [F1]Includes 4,741 shares acquired under the Issuer's Employee Stock Purchase Plan as follows: 2,276 shares acquired on May 20, 2021; 359 shares acquired on November 19, 2021; 993 shares acquired on May 20, 2022 and 1,113 shares acquired on November 21, 2022.
- [F2]Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025.